The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the Acute and Continuation Phases

  • Martin B. Keller
  • , Madhukar H. Trivedi
  • , Michael E. Thase
  • , Richard C. Shelton
  • , Susan G. Kornstein
  • , Charles B. Nemeroff
  • , Edward S. Friedman
  • , Alan J. Gelenberg
  • , James H. Kocsis
  • , David L. Dunner
  • , Boadie W. Dunlop
  • , Robert M. Hirschfeld
  • , Anthony J. Rothschild
  • , James M. Ferguson
  • , Alan F. Schatzberg
  • , John M. Zajecka
  • , Ron Pedersen
  • , Bing Yan
  • , Saeeduddin Ahmed
  • , Michael Schmidt
  • Philip T. Ninan

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the Acute and Continuation Phases'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science